Jasper Therapeutics Inc. (JSPR) Statistics & Valuation Metrics - Stocknear

Jasper Therapeutics Inc.

NASDAQ: JSPR · Real-Time Price · USD
2.72
0.03 (1.12%)
At close: Sep 05, 2025, 3:59 PM
2.72
0.00%
After-hours: Sep 05, 2025, 05:15 PM EDT

Jasper Therapeutics Statistics

Share Statistics

Jasper Therapeutics has 16.25M shares outstanding. The number of shares has increased by -0.55% in one year.

16.25M
-0.55%
0%
79.08%
13.62M
22,406
3.5%

Short Selling Information

The latest short interest is 1.23M, so 7.54% of the outstanding shares have been sold short.

1.23M
7.54%
7.63%
4.31

Valuation Ratios

The PE ratio is -4.38 and the forward PE ratio is -0.72. Jasper Therapeutics's PEG ratio is 0.21.

-4.38
-0.72
0
39.8
5.06
-4.94
0.21
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Jasper Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.03.

4.98
4.98
0.03
-0.03
-0.03
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.11M
64
0
n/a

Taxes

-1.49M
2.05%

Stock Price Statistics

The stock price has increased by -85.4% in the last 52 weeks. The beta is 2.78, so Jasper Therapeutics's price volatility has been higher than the market average.

2.78
-85.4%
3.38
7.68
37.83
639,691

Income Statement

n/a
-1.37M
-77.73M
-71.27M
-71.39M
-72.76M
-4.89
Full Income Statement

Balance Sheet

The company has 71.64M in cash and 1.81M in debt, giving a net cash position of 69.82M.

71.64M
1.81M
69.82M
-240.87M
46.47M
22.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -62.6M and capital expenditures -552K, giving a free cash flow of -63.15M.

-62.6M
-552K
-63.15M
-4.33
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for JSPR is $20, which is 635.3% higher than the current price. The consensus rating is "Buy".

$20
635.3%
Buy
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 4, 2024. It was a backward split with a ratio of 1:10.

Jan 4, 2024
backward
1:10

Scores

-13.41
0